MARKET

CDMO

CDMO

Avid Bioservices
NASDAQ

Real-time Quotes | Nasdaq Last Sale

8.94
+0.16
+1.82%
After Hours: 8.94 0 0.00% 13:10 11/27 EST
OPEN
8.74
PREV CLOSE
8.78
HIGH
9.08
LOW
8.74
VOLUME
147.36K
TURNOVER
--
52 WEEK HIGH
9.37
52 WEEK LOW
3.020
MARKET CAP
506.03M
P/E (TTM)
-66.0754
1D
5D
1M
3M
1Y
5Y
News
Financial
Releases
Corp Actions
Analysis
Profile
Are Investors Undervaluing Avid Bioservices, Inc. (NASDAQ:CDMO) By 44%?
Today we'll do a simple run through of a valuation method used to estimate the attractiveness of Avid Bioservices...
Simply Wall St. · 11/08 13:20
Is Avid Bioservices' (NASDAQ:CDMO) Share Price Gain Of 135% Well Earned?
Simply Wall St. · 09/24 14:29
Avid Bioservices Announces Move to Virtual-Only Annual Meeting of Stockholders on October 20, 2020
TUSTIN, Calif., Sept. 15, 2020 (GLOBE NEWSWIRE) -- Avid Bioservices, Inc. (NASDAQ:CDMO) (NASDAQ:CDMOP), today announced that it will hold its 2020 Annual Meeting of Stockholders (the “Annual Meeting”) solely by means of remote communication (i.e., a virtual-only stockholder meeting). This change is to
GlobeNewswire · 09/15 21:05
Avid Bioservices (CDMO) Has Risen 37% in Last One Year, Outperforms Market
If you are looking for the best ideas for your portfolio you may want to consider some of Laughing Water Capital's top stock picks. Laughing Water Capital, an investment management firm, is bullish on Avid Bioservices Inc. (NASDAQ:CDMO) stock. In its Q2 2019 investor letter – you can download a copy
Insider Monkey · 09/10 14:29
Avid Bioservices to Participate in 18th Annual Morgan Stanley Global Healthcare Conference
TUSTIN, Calif., Sept. 10, 2020 (GLOBE NEWSWIRE) -- Avid Bioservices, Inc. (NASDAQ:CDMO) (NASDAQ:CDMOP), a dedicated biologics contract development and manufacturing organization (CDMO) working to improve patient lives by providing high quality development and manufacturing services to biotechnology and
GlobeNewswire · 09/10 12:05
The Daily Biotech Pulse: Sanofi, GSK Begin Phase 1/2 Coronavirus Vaccine Study, Fulgent Strikes COVID-19 Testing Deal, New Data From Novavax
Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 2)
Benzinga · 09/03 11:55
The Daily Biotech Pulse: Amarin's Vascepa Appeal Hearing, Avid Bioservices' Strong Q1, A Life Sciences Blank Check IPO
Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 1)
Benzinga · 09/02 11:25
Avid Bio +5% after topping FQ1 expectations on expanded margins
Avid Bioservices ([[CDMO]]) Fiscal Q1 2021 results:Revenues: $25.4M (+66.0%).Gross margin for FQ1 was 34%, up significantly compared to 7% for Q1 2020. The increase was primarily due to increased manufacturing
Seekingalpha · 09/02 04:10
More
Forecast
EPSBVPSCFPS
Actual (USD)
Estimate (USD)
Income StatementMore
Net IncomeTotal RevenueOperating Income
Net Income (USD)
YoY (%)
Balance SheetMore
Total Assets (USD)
Total Liabilities (USD)
Debt to Asset (%)
Cash FlowMore
OperatingInvestingFinancing
Operating (USD)
YoY (%)
Learn about the latest financial forecast of CDMO. Analyze the recent business situations of Avid Bioservices through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.
Analyst Rating

Based on 3 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target
The average CDMO stock price target is 11.33 with a high estimate of 12.00 and a low estimate of 11.00.
EPS
Institutional Holdings
Institutions: 164
Institutional Holdings: 37.20M
% Owned: 65.72%
Shares Outstanding: 56.60M
TypeInstitutionsShares
Increased
25
2.71M
New
38
2.20M
Decreased
36
1.05M
Sold Out
0
0
  • Performance
  • Asset Allocation
  • Dividend History
No Data
Industry
Pharmaceuticals
+1.12%
Pharmaceuticals & Medical Research
+1.72%
Key Executives
Non-Executive Chairman/Independent Director
Joseph Carleone
President/Chief Executive Officer/Director
Nicholas Green
Chief Financial Officer
Daniel Hart
Chief Operating Officer
Richard Richieri
Vice President/General Counsel/Secretary
Mark Ziebell
Vice President
Magnus Schroeder
Other
Timothy Compton
Director
Richard Hancock
Other
Tim Compton
Independent Director
Mark Bamforth
Independent Director
Catherine Mackey
Independent Director
Gregory Sargen
Independent Director
Patrick Walsh
  • Dividends
  • Splits
  • Insider Activity
Declaration Date
Dividend Per Share
Ex-Div Date
03/07/2018
Dividend USD 0.6563
03/16/2018
Access Level 2 Advance
Nasdaq TotalView
for Free
Get Now
About CDMO
Avid Bioservices, Inc. is a contract development and manufacturing organization (CDMO). The Company is focused on development and Current Good Manufacturing Practices (CGMP) manufacturing of biopharmaceutical products derived from mammalian cell culture. The Company provides a range of process development, CGMP clinical and commercial manufacturing services for the biotechnology and biopharmaceutical industries. The Company’s services include CGMP clinical and commercial product manufacturing, purification, bulk packaging, stability testing and regulatory strategy, submission and support. The Company also provides process development activities, including cell line development and optimization, cell culture and feed optimization, analytical methods development and product characterization.
More
Hot Stocks
Symbol
Price
%Change

Webull offers kinds of Avid Bioservices Inc stock information, including NASDAQ:CDMO real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, CDMO stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading CDMO stock methods without spending real money on the virtual paper trading platform.